RIL
SUPN icon

Rothschild Investment LLC’s Supernus Pharmaceuticals SUPN Stock Holding History

Rothschild Investment LLC’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Buy
383
+303
+379% +$14.6K ﹤0.01% 1591
2026
Q1 		$4.13K Hold
80
– – ﹤0.01% 2153
2025
Q4 		$3.98K Hold
80
– – ﹤0.01% 2011
2025
Q3 		$3.82K Buy
80
+15
+23% +$604 ﹤0.01% 1829
2025
Q2 		$2.05K Buy
65
+25
+63% +$801 ﹤0.01% 2065
2025
Q1 		$1.31K Buy
40
+5
+14% +$177 ﹤0.01% 2179
2024
Q4 		$1.27K Hold
35
– – ﹤0.01% 2071
2024
Q3 		$1.09K Buy
35
+20
+133% +$624 ﹤0.01% 2108
2024
Q2 		$401 Buy
15
+10
+200% +$290 ﹤0.01% 2156
2024
Q1 		$171 Buy
+5
New +$149 ﹤0.01% 1829

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Rothschild Investment LLC's SUPN Position: Q2 2026 in Review

Rothschild Investment LLC increased its Supernus Pharmaceuticals (SUPN) stake by 379% in Q2 2026, buying an estimated $14.6K and bringing the position to 383 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

Rothschild Investment LLC first reported a position in SUPN in Q1 2024 and has held it in 10 quarters since. 311 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Rothschild Investment LLC held 383 shares of Supernus Pharmaceuticals worth $17.8K as of Q2 2026.
  • Rothschild Investment LLC bought 303 Supernus Pharmaceuticals shares in Q2 2026, an estimated $14.6K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1591 holding.
  • Rothschild Investment LLC first reported a position in Supernus Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 311 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.